/BBBT
BBBT Stock - Black Bird Biotech, Inc.
Healthcare|Drug Manufacturers - Specialty & GenericOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
55
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.50
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.38
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for BBBT
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.05
52W High$0.00
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $82,563 | $104,458 | $57,604 | $17,771 | N/A |
| Gross Profit | $-55,906 | $19,587 | $29,359 | $-31 | N/A |
| Gross Margin | -67.7% | 18.8% | 51.0% | -0.2% | N/A |
| Operating Income | $-1,288,333 | $-1,451,127 | $-684,803 | $-80,306 | $-83,538 |
| Net Income | $-1,658,766 | $-1,811,302 | $-691,570 | $-163,628 | $-121,110 |
| Net Margin | -2009.1% | -1734.0% | -1200.6% | -920.8% | N/A |
| EPS | $-0.01 | $-0.01 | $-0.01 | $-0.00 | $-0.00 |
Company Overview
Black Bird Biotech Inc. provides various biotech products. It manufactures and distributes MiteXstream, a plant-based biopesticide for the eradication of spider mites. The company also manufactures and sells CBD Oils, gummies and pet treats, CBD-infused personal care products, and hand sanitizer gel and spray products under the Grizzly Creek Naturals brand name. In addition, it grows industrial hemp under the Montana Hemp pilot program. The company was formerly known as Digital Development Partners, Inc. and changed its name to Black Bird Biotech, Inc. in June 2021. Black Bird Biotech, Inc. is based in Flower Mound, Texas.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
BBBTBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-0.00
Q4 2023
EPS Surprise History
Q2 22
No data
Q2 22
No data
Q3 22
No data
Q4 22
No data
Q1 23
No data
Q2 23
No data
Q3 23
No data
Q4 23
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2024 | Nov 19, 2024 | — | — | — | — |
Q2 2024 | Jun 3, 2024 | — | — | — | — |
Q2 2024 | May 9, 2024 | — | — | — | — |
Q1 2024 | Feb 19, 2024 | — | — | — | — |
Q4 2023 | Nov 20, 2023 | — | $-0.00 | — | — |
Q3 2023 | Aug 21, 2023 | — | $-0.00 | — | — |
Q2 2023 | May 22, 2023 | — | $-0.00 | — | — |
Q1 2023 | Mar 21, 2023 | — | $-0.00 | — | — |
Q4 2022 | Nov 14, 2022 | — | $-0.00 | — | — |
Q3 2022 | Aug 23, 2022 | — | $-0.00 | — | — |
Q2 2022 | May 23, 2022 | — | $-0.00 | — | — |
Q2 2022 | Apr 15, 2022 | — | $-0.00 | — | — |
Q4 2021 | Nov 22, 2021 | — | $-0.00 | — | — |
Q3 2021 | Aug 23, 2021 | — | $-0.00 | — | — |
Q2 2021 | May 24, 2021 | — | $-0.00 | — | — |
Q2 2021 | Apr 15, 2021 | — | $-0.01 | — | — |
Q4 2020 | Nov 23, 2020 | — | $-0.00 | — | — |
Q3 2020 | Aug 20, 2020 | — | $-0.00 | — | — |
Q3 2020 | Aug 10, 2020 | — | $-0.00 | — | — |
Q3 2020 | Jul 14, 2020 | — | $-0.00 | — | — |
Latest News
Loading news...
Frequently Asked Questions about BBBT
What is BBBT's current stock price?
Black Bird Biotech, Inc. (BBBT) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for BBBT?
No analyst price targets are currently available for this stock.
What sector is Black Bird Biotech, Inc. in?
Black Bird Biotech, Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.
What is BBBT's market cap?
Black Bird Biotech, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does BBBT pay dividends?
No, Black Bird Biotech, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorADVT
Advantis Corp.
$0.00
Mkt Cap: $0.0B
CANL
CannLabs, Inc.
$0.00
Mkt Cap: $0.0B
EAPH
Parallel Industries Inc.
$0.00
Mkt Cap: $0.0B
GCAN
The Greater Cannabis Company, Inc.
$0.08
Mkt Cap: $0.0B
GREH
Green Rain Energy Holdings Inc.
$0.00
Mkt Cap: $0.0B
NVOS
Novo Integrated Sciences, Inc.
$0.00
Mkt Cap: $0.0B
PBLA
Panbela Therapeutics, Inc.
$0.00
Mkt Cap: $0.0B
REZNF
Street Capital Inc.
$0.00
Mkt Cap: $0.0B
WRHLF
Love Hemp Group Plc
$0.00
Mkt Cap: $0.0B
XTXXF
Adastra Holdings Ltd.
$0.02
Mkt Cap: $0.0B
Explore stocks similar to BBBT for comparison